These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15140620)

  • 21. Remission of demyelinating polyneuropathy with immunoadsorption, low dose corticosteroids and anti-CD20 monoclonal antibody.
    Rech J; Hueber AJ; Kallert S; Leipe J; Kalden JR; Beck M; Schett G; Schulze-Koops H
    Ther Apher Dial; 2008 Jun; 12(3):205-8. PubMed ID: 18503697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotective effect of the immune system in a mouse model of severe dysmyelinating hereditary neuropathy: enhanced axonal degeneration following disruption of the RAG-1 gene.
    Berghoff M; Samsam M; Müller M; Kobsar I; Toyka KV; Kiefer R; Mäurer M; Martini R
    Mol Cell Neurosci; 2005 Jan; 28(1):118-27. PubMed ID: 15607947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relevant antibodies in dysimmune neuropathies].
    Gallardo E; Rojas R; Illa I
    Rev Neurol; 2000 Mar 16-31; 30(6):510-4. PubMed ID: 10863722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential diagnosis of chronic dysimmune demyelinating polyneuropathies with and without anti-MAG antibodies.
    Isoardo G; Migliaretti G; Ciaramitaro P; Rota E; Poglio F; Tavella A; Paolasso I; Cavallo F; Bergamasco B; Cocito D
    Muscle Nerve; 2005 Jan; 31(1):52-8. PubMed ID: 15536620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose rituximab and anti-MAG-associated polyneuropathy.
    Renaud S; Fuhr P; Gregor M; Schweikert K; Lorenz D; Daniels C; Deuschl G; Gratwohl A; Steck AJ
    Neurology; 2006 Mar; 66(5):742-4. PubMed ID: 16534115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further comparisons of assays for detecting MAG IgM autoantibodies.
    Jaskowski TD; Prince HE; Greer RW; Litwin CM; Hill HR
    J Neuroimmunol; 2007 Jul; 187(1-2):175-8. PubMed ID: 17537521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The co-inhibitory molecule PD-1 modulates disease severity in a model for an inherited, demyelinating neuropathy.
    Kroner A; Schwab N; Ip CW; Sommer C; Wessig C; Wiendl H; Martini R
    Neurobiol Dis; 2009 Jan; 33(1):96-103. PubMed ID: 18996482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnostic value of autoantibodies to MAG by ELISA Bühlmann in 117 immune-mediated peripheral neuropathies associated with monoclonal IgM to SGPG/SGLPG].
    Caudie C; Kaygisiz F; Jaquet P; Petiot P; Gonnaud PM; Antoine JC; Vial C
    Ann Biol Clin (Paris); 2006; 64(4):353-9. PubMed ID: 16829480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy.
    Kuijf ML; Eurelings M; Tio-Gillen AP; van Doorn PA; van den Berg LH; Hooijkaas H; Stork J; Notermans NC; Jacobs BC
    Neurology; 2009 Sep; 73(9):688-95. PubMed ID: 19720975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in the understanding of the immunological basis of peripheral neuropathies.
    Larner AJ
    Br J Clin Pract; 1993; 47(5):262-5. PubMed ID: 8292474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demyelinative neuropathy and myelin antibodies.
    Asbury AK; Lisak RP
    N Engl J Med; 1980 Sep; 303(11):638-9. PubMed ID: 6250030
    [No Abstract]   [Full Text] [Related]  

  • 32. Myelin-associated glycoprotein and galactosylcerebroside expression in Schwann cells during myelination.
    Päiväläinen S; Heape AM
    Mol Cell Neurosci; 2007 Jul; 35(3):436-46. PubMed ID: 17513122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [IgM anti-MAG neuropathy with involvement of the cranial nerves disclosing B-cell lymphoma].
    Maillot F; Gelot A; Diot E; Larmande P; Guilmot JL
    Ann Med Interne (Paris); 1996; 147(5):373-4. PubMed ID: 9033744
    [No Abstract]   [Full Text] [Related]  

  • 34. The composition of the inflammatory infiltrate in three cases of polyneuritis equi.
    van Galen G; Cassart D; Sandersen C; Delguste C; Nollet H; Amory H; Ducatelle R
    Equine Vet J; 2008 Mar; 40(2):185-8. PubMed ID: 18267887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel function of RING finger protein 10 in transcriptional regulation of the myelin-associated glycoprotein gene and myelin formation in Schwann cells.
    Hoshikawa S; Ogata T; Fujiwara S; Nakamura K; Tanaka S
    PLoS One; 2008; 3(10):e3464. PubMed ID: 18941509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgM deposits on skin nerves in anti-myelin-associated glycoprotein neuropathy.
    Lombardi R; Erne B; Lauria G; Pareyson D; Borgna M; Morbin M; Arnold A; Czaplinski A; Fuhr P; Schaeren-Wiemers N; Steck AJ
    Ann Neurol; 2005 Feb; 57(2):180-7. PubMed ID: 15668968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophages and abnormal BCL-6 or c-MYC gene expression affect the resistance of peritoneal B cells to induction of hyporesponsiveness.
    Liou LB; Wu MW; Chao WJ
    Scand J Immunol; 2009 May; 69(5):447-56. PubMed ID: 19508376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No cytomegalovirus DNA in sera from patients with anti-MAG/SGPG antibody-associated neuropathy.
    Irie S; Kanazawa N; Ogino M; Saito T; Funato T
    Ann Neurol; 2000 Feb; 47(2):274-5. PubMed ID: 10665505
    [No Abstract]   [Full Text] [Related]  

  • 39. Immune circuitry in the peripheral nervous system.
    Kieseier BC; Hartung HP; Wiendl H
    Curr Opin Neurol; 2006 Oct; 19(5):437-45. PubMed ID: 16969152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-titer immunoglobulin M antibody to nerve-specific class III beta-tubulin in the serum of a patient with sensory demyelinating polyneuropathy.
    Stubbs EB; Fisher MA; Wilson JR; Siegel GJ
    Muscle Nerve; 1996 Dec; 19(12):1638-9. PubMed ID: 8941286
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.